Back to search results

Effect of Early Use of Levosimendan Versus Placebo on Top of a Conventional Strategy of Inotrope Use on a Combined Morbidity-mortality Endpoint in Patients With Cardiogenic Shock

Abroad (travel likely)RecruitingPHASE3

Conditions

Cardiogenic Shock

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • CHRU Strasbourg -Nouvel Hôpital Civil, Strasbourg, Bas-Rhin, France

    Contact: Study coordinator (Ferhat MEZIANI, MD-PhD)
    Contact: Principal Investigator (Ferhat MEZIANI, MD-PhD)

  • AP-HM, Nord Hospital, Marseille, Marseille, Bouches du Rhône, France

    Contact: Study coordinator (Laurent Bonello, MD)
    Contact: Principal Investigator (Laurent Bonello, MD)

  • CHU Caen, Caen, Calvados, France

    Contact: Study coordinator (Katrien Blanchart, MD)
    Contact: Principal Investigator (Katrien Blanchart, MD)

  • CHU Dijon, Dijon, Côte d'Or, France

    Contact: Study coordinator (Jean-Pierre Quenot, MD-PhD)
    Contact: Principal Investigator (Jean-Pierre Quenot, MD-PhD)

  • CHU Besançon Jean Minjoz Hospital, Besançon, Doubs, France

    Contact: Study coordinator (Hadrien WINISZEWSKI, MD)
    Contact: Principal Investigator (Hadrien WINISZEWSKI, MD)

  • CHU Nîmes, Carémeau Hospital, Nîmes, Gard, France

    Contact: Study coordinator (Benoît Lattuca, MD)
    Contact: Principal Investigator (Benoît Lattuca, MD)

  • CHU Bordeaux - Hopital haut-leveque, Bordeaux, Gironde, France

    Contact: Study coordinator (Edouard Gerbaud, MD)
    Contact: Principal Investigator (Edouard Gerbaud, MD)

  • CHU de Toulouse, Toulouse, Haute-Garonne, France

    Contact: Study coordinator (Clément Delmas, MD)
    Contact: Principal Investigator (Clément Delmas, MD)

  • CHU Limoges, Dupuytren Hospital, Limoges, Haute-Vienne, France

    Contact: Study coordinator (Philippe Vignon, MD)
    Contact: Principal Investigator (Philippe Vignon, MD)

  • CHU Montpellier, Arnaud de Villeneuve Hospital, Montpellier, Hérault, France

    Contact: Study coordinator (François Roubille, MD)
    Contact: Principal Investigator (François Roubille, MD)

  • CHU Rennes, Pontchaillou Hospital, Rennes, Ille et Vilaine, France

    Contact: Study coordinator (Abdelkader BAKHTI, MD)
    Contact: Principal Investigator (Abdelkader BAKHTI, MD)

  • CHU Grenoble, Michallon Hospital, La Tronche, Isère, France

    Contact: Study coordinator (Joanna Bougnaud, MD)
    Contact: Principal Investigator (Joanna Bougnaud, MD)

  • CHU Nantes, Nantes, Loire-Atlantique, France

    Contact: Study coordinator (Julien Plessis, MD)
    Contact: Principal Investigator (Julien Plessis, MD)

  • CHR Metz-Thionville, Mercy Hospital, Ars-Laquenexy, Moselle, France

    Contact: Study coordinator (Guillaume Louis, MD)
    Contact: Principal Investigator (Guillaume Louis, MD)

  • CHRU Lille, Cœur Poumon Institute, Lille, Nord, France

    Contact: Study coordinator (Gilles LEMESLE, MD-PhD)
    Contact: Principal Investigator (Gilles LEMESLE, MD-PhD)

  • APHP, La Pitié Salpêtrière (medical intensive care unit), Paris, Paris, France

    Contact: Study coordinator (Alain Combes, MD)
    Contact: Principal Investigator (Alain Combes, MD)

  • Hospices Civils de Lyon - Louis Pradel Hospital, Bron, Rhône, France

    Contact: Study coordinator (Bertrand SCHEPPLER, MD) · bertrand.scheppler01@chu-lyon.fr · +33 4 72 11 80 88
    Contact: Principal Investigator (Bertrand SCHEPPLER, MD)

  • APHP, Henri Mondor Hospital, Créteil, Val de Marne, France

    Contact: Study coordinator (Raphaëlle HUGUET, MD) · raphaelle.huguet@aphp.fr · +33 1 49 81 21 11
    Contact: Principal Investigator (Raphaelle HUGUET, MD)

  • CH Henri Duffaut, Avignon, Avignon, Vaucluse, France

    Contact: Study coordinator (Stéphane Andrieu, MD)
    Contact: Principal Investigator (Stéphane Andrieu, MD)

  • CHU Bordeaux, Bordeaux, France

    Contact: Study coordinator (Alexandre OUTARRA, MD-PhD)
    Contact: Principal Investigator (Alexandre OUTARRA, Md-PhD)

  • HENRI MONDOR -réanimation, Créteil, France

    Contact: Study coordinator (Armand MEKONTSO DESSAP, MD-Phd) · armand.dessap@aphp.fr · +33 1 49 81 21 11
    Contact: Principal Investigator (Armand MEKONTSO DESSAP, MD-PhD)

  • Chu Dijon, Dijon, France

    Contact: Study coordinator (Pierre Grégoire GUINOT, MD-PhD)
    Contact: Principal Investigator (Pierre Grégoire GUINOT, MD-PhD)

  • CHU Grenoble -USIC, La Tronche, France

    Contact: Study coordinator (Nicolas PILIERO, MD)
    Contact: Principal Investigator (Nicolas PILIERO, MD)

  • AP-HM CHU la Timone, Marseille, France

    Contact: Study coordinator (Florent ARREGLE, MD)
    Contact: Principal Investigator (Florent ARREGLE, MD)

  • CHU Montpellier -hôpital Arnaud de Villeneuve, Montpellier, France

    Contact: Study coordinator (Philippe GAUDARD, MD-PhD)
    Contact: Principal Investigator (Philippe GAUDARD, MD-PhD)

  • Chu Rouen, Rouen, France

    Contact: Study coordinator (Emmanuel BESNIER, MD-PhD)
    Contact: Principal Investigator (Emmanuel BESNIER, MD-PhD)

  • HU Strasbourg USIC, Strasbourg, France

    Contact: Study coordinator (Olivier MOREL, MD PhD) · olivier.morel@chru-strasbourg.fr · +33 3 88 11 67 68
    Contact: Principal Investigator (Olivier MOREL, MD-pHD)

  • CHRU Nancy, Vandœuvre-lès-Nancy, France

    Contact: Study coordinator (Bruno Lévy, Prof)
    Contact: Principal Investigator (Bruno LEVY, Prof)
Study leads

  • Clément DELMAS, Dr

    Study Chair

    University Hospital, Toulouse

  • Nicolas GIRERD, Pr

    Study Chair

    CHRU Nancy

  • Patrick ROSSIGNOL, Pr

    Study Chair

    CHRU Nancy

View source on ClinicalTrials.gov(opens in a new tab)